IP Library › Granted Patent US 7,306,910
Granted Patent B2
US 7,306,910 · App. 10/422,522 · Granted Dec 11, 2007

Breast cancer prognostics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,306,910
App. No.
10/422,522
Granted
Dec 11, 2007
Kind
B2
Abstract

A method of providing a prognosis of breast cancer is conducted by analyzing the expression of a group of genes. Gene expresson profiles in a variety of medium such as microarrays are included as are kits that contain them.

Claims (1)

1. A method of predicting breast cancer recurrence comprising identifying differential modulation of each gene in a combination of genes selected for their ability to predict breast cancer recurrence wherein the genes comprise Seq. ID No. 1-56.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2003
From: WANG, YIXIN
To: VERIDEX, LCC
Reel/Frame 014582/0393 →